Free Trial

Tandem Diabetes Care (TNDM) Earnings Date, Estimates & Call Transcripts

Tandem Diabetes Care logo
$35.91 +2.64 (+7.94%)
(As of 12/20/2024 05:31 PM ET)

Tandem Diabetes Care Latest Earnings Summary

Latest Q3 2024
Earnings Date
Nov. 6Confirmed
Actual EPS
(Nov. 6)
-$0.35 Beat By $0.08
Consensus EPS
(Nov. 6)
-$0.43

Tandem Diabetes Care announced Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.35, which beat the consensus estimate of -$0.43 by $0.08. Quarterly revenue rose 31.4% year-over-year to $243.97 million, above analyst estimates of $224.14 million. With a trailing EPS of -$1.93, Tandem Diabetes Care's earnings are expected to grow next year, from ($1.68) to ($1.20) per share.

Get Tandem Diabetes Care Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tandem Diabetes Care and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TNDM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TNDM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Tandem Diabetes Care Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.78-$0.63-$0.71
Q2 20242-$0.53-$0.45-$0.49
Q3 20242-$0.44-$0.25-$0.35
Q4 20242-$0.13$0.13$0.00
FY 20248-$1.88-$1.20-$1.54
Q1 20252-$0.66-$0.42-$0.54
Q2 20252-$0.38-$0.37-$0.38
Q3 20251-$0.08-$0.08-$0.08
Q4 20251-$0.10-$0.10-$0.10
FY 20256($1.22)($0.97)($1.10)

Tandem Diabetes Care Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2024Q3 2024-$0.43-$0.35+$0.08-$0.37$224.14M$243.97M
8/1/2024Q2 2024-$0.54-$0.47+$0.07-$0.47$205.63M$221.90M
5/2/2024Q1 2024-$0.80-$0.63+$0.17-$0.61$173.06M$191.67M
2/21/2024Q4 2023-$0.23-$0.27 -$0.04-$0.08$204.86M$196.80M
11/1/2023Q3 2023-$0.35-$0.38 -$0.03-$0.25$193.33M$185.62M
8/3/2023Q2 2023-$0.54-$0.30+$0.24-$0.05$201.62M$195.92M
5/3/2023Q1 2023-$0.56-$0.63 -$0.07$0.66$171.59M$169.38M
2/22/2023Q4 2022-$0.0160-$0.01+$0.0060$0.23$221.99M$223.45M

Tandem Diabetes Care Earnings - Frequently Asked Questions

Tandem Diabetes Care (NASDAQ:TNDM) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on TNDM's earnings history.

Tandem Diabetes Care updated its FY 2024 earnings guidance on Wednesday, November, 6th. The company issued revenue guidance of $903.0 million-$910.0 million, compared to the consensus revenue estimate of $891.0 million.

In the previous quarter, Tandem Diabetes Care (NASDAQ:TNDM) reported ($0.35) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.43) by $0.08. Learn more on analysts' earnings estimate vs. TNDM's actual earnings.

The conference call for Tandem Diabetes Care's latest earnings report can be listened to online.
Listen to Conference Call

Tandem Diabetes Care's earnings report can be found in their filing with the SEC.
View SEC filing

Tandem Diabetes Care (NASDAQ:TNDM) has a recorded annual revenue of $854.35 million.

Tandem Diabetes Care (NASDAQ:TNDM) has a recorded net income of -$222.61 million. TNDM has generated -$1.93 earnings per share over the last four quarters.

Tandem Diabetes Care's earnings are expected to grow from ($1.68) per share to ($1.20) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:TNDM) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners